SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Microcap & Penny Stocks : Genesis Media Group, Inc (GNNX) -- Ignore unavailable to you. Want to Upgrade?


To: Tom Brown who wrote (2265)9/22/1998 3:56:00 PM
From: Mike Sawyer  Read Replies (3) | Respond to of 3129
 
A copy of Tom's email:

Dear Mr. Brown,

You are welcome for the replies. I did promise to respond to all within a reasonable time frame. As for the unanswered questions that you posed to me, here goes; In regards to the cost of TNNS - is about .26 cents per share. You also requested the cost & percentage of ownership for G.E.N. and M4 Radio. As for G.E.N. ( our vitamin company) Genesis owns 100% interest of G.E.N. and the cost
was 850,000 shares under Rule 144 Restricted Genesis stock. M4 Radio - which is our radio station out of Florida - Genesis owns 80% and the cost is 500,000 shares under Rule 144 Restricted. For you final question in regards to the sources of revenue for the first two quarters; Genesis has produced revenues from it's core business of music distribution, commercial contracts, media consulting, and editing and production work, i.e. commercial and info-commercials.
I went on the thread yesterday and read some of the shareholders ridiculous accusations. I hope this information will keep them quiet. There are some very serious accusations that they are making against the company. If they feel like that they should schedule an appointment to come in and check out our facilities. That's why we have an open door policy. With the accusations they are making it's no wonder that the stock price is falling. I hope I have put your mind at ease.

Best Regards,
Tina O'Brien.